Showing 1,741 - 1,760 results of 2,974 for search '"drug interaction"', query time: 0.19s Refine Results
  1. 1741

    HIV-Associated Tuberculosis in Children and Adolescents: Evolving Epidemiology, Screening, Prevention and Management Strategies by Alexander W. Kay, Helena Rabie, Elizabeth Maleche-Obimbo, Moorine Penninah Sekadde, Mark F. Cotton, Anna M. Mandalakas

    Published 2021-12-01
    “…HIV can impact TB screening and diagnosis by altering screening and diagnostic test performance and can complicate prevention and treatment strategies due to drug–drug interactions. Post-tuberculosis lung disease is an underappreciated phenomenon in children and adolescents, but is more commonly observed in children and adolescents with HIV-associated tuberculosis. …”
    Get full text
    Article
  2. 1742

    Istradefylline: A novel agent in the treatment of “off” episodes associated with levodopa/carbidopa use in Parkinson disease by Lauren Cummins, Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP

    Published 2022-01-01
    “…Istradefylline is taken once daily as a 20- or 40-mg dose, except in cases involving drug interactions or hepatic impairment. The cost of the drug is relatively expensive, which has implications for Medicare and private insurance coverage. …”
    Get full text
    Article
  3. 1743

    R263K Mutation Leading to Failure of Dolutegravir-Based Treatment in a HIV Patient also Receiving Rifampicin: A Case Report by Jin Li, Zhiwei Wen, Yili Chen, Sichun Yin

    Published 2023-05-01
    “…Due to the DTG drug-drug interactions with rifampicin, the dose of DTG should be doubled when used with rifampicin. …”
    Get full text
    Article
  4. 1744

    Risk factors for adverse drug reactions associated with clopidogrel therapy by Mugosa Snezana, Radosavljevic Ivan, Sahman Majda, Djordjevic Natasa, Todorovic Zoran

    Published 2022-04-01
    “…This study aimed to investigate the possible influence of genetic and non-genetic factors on the incidence of clopidogrel adverse drug reactions (ADRs) in cardiology patients, including the most important CYP2C19 alleles, namely *2 and *17, as well as compliance, dose, drug interactions, and clinical factors. A total of 102 clopidogrel-treated adult Caucasian patients hospitalized at the Cardiology Department of the Clinical Center of Montenegro were enrolled in the study. …”
    Get full text
    Article
  5. 1745

    Functional Foods may be Dysfunctional: A South Asian Perspective by Bharti Kalra, Leepica Kapoor, Suneet Verma, Sanjay Kalra

    Published 2023-12-01
    “…Keywords: Diabetes, drug interactions, food interactions, seeds, semaglutide, spices, thyroxine. …”
    Get full text
    Article
  6. 1746

    Cutaneous Alternariosis in Immunosuppressed Patients Treated with Photodynamic Therapy and Oral Antifungals, a Synergistic Strategy by Pedro Gil-Pallares, Tamara Gracia-Cazaña, Marcial Álvarez-Salafranca, Marcos Antonio Gorgojo, Mar García-García, Antonio Beltrán-Rosel, Manuel Almenara-Blasco, Alba Navarro-Bielsa, Yolanda Gilaberte

    Published 2024-02-01
    “…The presented series shows three cases of cutaneous alternariosis in immunocompromised patients and organ transplant recipients that were successfully treated with photodynamic therapy and oral antifungals, allowing a reduction in the systemic treatment duration and therefore decreasing the risk of side effects and drug interactions.…”
    Get full text
    Article
  7. 1747

    A survey-based inventory of clinical decision support systems in computerised provider order entry in Swiss hospitals by Delphine Carli-Ghabarou, Hanna M Seidling, Pascal Bonnabry, Christian Lovis

    Published 2013-12-01
    “…The type of CDSS most frequently implemented was information on hospital formularies (n = 13) and drug-drug interactions (n = 11), but CDSSs with regard to genotype, drug interactions with laboratory test results, contraindications, specific age groups and necessary drug orders were only rarely implemented. …”
    Get full text
    Article
  8. 1748

    The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation by O. O. Shakhmatova

    Published 2020-12-01
    “…For edoxaban, an adequate approach to dose reduction has been developed in patients with alikely increase in plasma concentration due to renal impairment, low body weight or inter-drug interactions. Such dose reduction does notlead to an increase in the frequency of ischemic complications.Edoxaban is characterized by an optimal safety profile in patients with chronic moderate kidney disease, a small number of drug interactions and a convenient mode of administration. …”
    Get full text
    Article
  9. 1749

    Antihistamines in the treatment of allergic rhinitis by A. L. Guseva, M. L. Derbeneva

    Published 2020-05-01
    “…This drug does not interact with the P450 cytochrome system or undergo significant metabolism in the human body, and therefore the drug has low potential for drug-drug interactions. Bilastine is excreted almost completely unchanged and therefore does not require dose adjustment in patients with renal or hepatic impairment. …”
    Get full text
    Article
  10. 1750

    RETRACTED: Efficacy and safety of medicines: the value and opportunities of clinical pharmacology by M. V. Zhuravleva, V. G. Kukes, A. B. Prokofiev, V. V. Arkhipov, Yu. V. Olefir, S. Yu. Serebrova, A. V. Sokolov, D. A. Sychev

    Published 2018-02-01
    “…RETRACTED ARTICLEBrief description of the opportunities and benefits of applying the methodology of clinical pharmacology and personalized medicine, pharmacokinetics, and pharmacodynamics of medicines, as well as the possibilities of evaluation of metabolic biotransformation and drug interactions to improve the efficacy, safety, therapeutic and pharmacodynamic effects of medicines, is given. …”
    Get full text
    Article
  11. 1751

    Management of Hypertensive patient in the Dental Office - Current Concepts by T Maheswaran, M Jonathan Daniel, N R Bhat, S V Srinivasan

    Published 2006-01-01
    “…Adverse oral effects and drug interactions of antihypertensive medications further indicates special considerations for the hypertensive patient. …”
    Get full text
    Article
  12. 1752

    Current Approach of Corticosteroids Use in Ocular Therapy. by Dayamí Pérez Gómez, Ivonne González Parra, Francisco García González

    Published 2011-08-01
    “…Aspects related to the type of administration of corticosteroids and the possible adverse reactions and drug interactions are included.…”
    Get full text
    Article
  13. 1753

    Diabetes Fever by Sanjay Kalra, Suneet Verma, Nitin Kapoor, Saptarshi Bhattacharya

    Published 2024-02-01
    “…We highlight the bidirectional interactions between febrile illness and diabetes, as well as drug-drug interactions. These multifaceted connections must be understood by all health care professionals who manage diabetes and/or fever. …”
    Get full text
    Article
  14. 1754

    Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase by Kundu, Subhashri, Biukovic, Goran, Grüber, Gerhard, Dick, Thomas

    Published 2017
    “…Using the purified ε subunit of the synthase and spectroscopy, we previously demonstrated that the drug interacts with this protein near its unique tryptophan residue. …”
    Get full text
    Get full text
    Journal Article
  15. 1755

    Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association? by Nadiya Hussain, Muntaha Naeem, David J. Pinato

    Published 2021-01-01
    “…As immune checkpoint inhibitors expand in the treatment of a widening range of malignancies, drug–drug interactions have become an area of increasing interest due to the potential for some concomitant medications to exert immune-modulatory effects and influence outcomes from immunotherapy. …”
    Get full text
    Article
  16. 1756

    Review of the Use of Medicinal Cannabis Products in Palliative Care by James Troyer, Kimberson Tanco

    Published 2024-04-01
    “…Cannabis-based products have adverse effects, ranging from neuropsychiatric to systemic effects to potential drug interactions.…”
    Get full text
    Article
  17. 1757

    Comparative analysis of newer classes of antidiabetics and the concept of pharmaceutical care – dealing with therapeutic problems by Anna Peneva, Milen Dimitrov, Valentina Petkova

    Published 2024-02-01
    “…After pharmacodynamic, pharmacokinetic, clinical and pharmacoepidemiologic data analysis and comparison of the three classes of antidiabetic medicinal products: GLP-1 receptor agonists, DPP-4 inhibitors and SGLT2 inhibitors, a literature review of the topic, patient education and the concept of pharmaceutical care emerged as methods for dealing with the most common adverse drug reactions, safety concerns, and drug interactions.…”
    Get full text
    Article
  18. 1758

    Disseminated lung tuberculosis and tuberculosis meningoencephalitis after kidney transplantation by B. I. Yaremin, I. L. Tsygankov, L. A. Baryshnikova, A. A. Starostina, V. E. Aleksandrova, U. V. Maslikova

    Published 2018-09-01
    “…The issues of drug therapy and drug interactions with anti-tuberculosis and immunosuppressive agents have been discussed.…”
    Get full text
    Article
  19. 1759

    Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature by Lawrence Kasherman, Jeffrey Doi, Katherine Karakasis, Jeffrey Schiff, Abhijat Kitchlu, Stephanie Lheureux, Amit M. Oza

    Published 2021-01-01
    “…We present a case of recurrent high-grade serous ovarian carcinoma treated with paclitaxel and bevacizumab in the context of prior renal transplantation where the patient responded well to treatment with controlled toxicities, discussing the potential for increased rates of adverse events and drug interactions in this select population.…”
    Get full text
    Article
  20. 1760

    Simultaneous pancreas kidney transplantation in the HIV-positive patient. by Akhtar, M, Patel, N, Devaney, A, Sinha, S, Shankar, S, Vaidya, A, Friend, P

    Published 2011
    “…We reflect on the article recently published by Miro et al in Transplantation Proceedings and highlight strategies used by our department to prevent drug interactions in these complex patients.…”
    Journal article